U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H14N2O2
Molecular Weight 218.2518
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FONTURACETAM

SMILES

NC(=O)CN1CC(CC1=O)C2=CC=CC=C2

InChI

InChIKey=LYONXVJRBWWGQO-UHFFFAOYSA-N
InChI=1S/C12H14N2O2/c13-11(15)8-14-7-10(6-12(14)16)9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,13,15)

HIDE SMILES / InChI

Molecular Formula C12H14N2O2
Molecular Weight 218.2518
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Fonturacetam, also known as Phenylpiracetam, is marketed in Russia as Carphedon and Phenotropil. It is one of the first ever nootropic drugs and originally discovered in Russia. Fonturacetam acts on most neurotransmitter systems and has been used for its cognitive and physical enhancing properties, and also as an antidepressant.

CNS Activity

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
5.8 µM [IC50]

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
phenotropil
Primary
phenotropil
Primary
phenotropil
Primary
phenotropil
Primary
phenotropil

PubMed

Sample Use Guides

In Vivo Use Guide
A Russian manufacturer of Phenotropil recommends 100 mg per day.
Route of Administration: Oral
In Vitro Use Guide
In vitro, phenotropil (IC50 = 5.86 μM) directly influenced α4β2 nicotinic acetylcholine receptors in the mouse brain cortex.
Substance Class Chemical
Record UNII
99QW5JU66Y
Record Status Validated (UNII)
Record Version